[Methodological monitoring of the effects of endocrine disruptors in complex health maintenance].

IF 0.9 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL
Krisztián Sepp, Péter Sándor Kiss, Anna László, Zsuzsanna Valkusz, Marianna Radács, Márta Gálfi, Zsolt Molnár
{"title":"[Methodological monitoring of the effects of endocrine disruptors in complex health maintenance].","authors":"Krisztián Sepp, Péter Sándor Kiss, Anna László, Zsuzsanna Valkusz, Marianna Radács, Márta Gálfi, Zsolt Molnár","doi":"10.1556/650.2025.33353","DOIUrl":null,"url":null,"abstract":"<p><p>Introduction: By the 3rd millennium, the Earth as a living environment had been altered by environmental stresses. For 25 years, our research group has been thematically engaged in model studies of homeostatic disruptor effects. These have enabled thematic studies to follow the effects of chemical agents, e.g., the combined effects of chlorobenzenes (hexachlorobenzene : 1,2,4-trichlorobenzene 1 : 1), which have endocrine disrupting properties. Objective: We aimed to develop a test model system to investigate the effects of endocrine disruptors in a validated test system. Method: In the test system, male and female Wistar rats were used as model animals for in vivo studies. Subtoxicity was controlled by liver enzymes and body weight and physiological characterization. The exposure pathway was standardized. Then, the organism-level sub-toxic dose range and the time windows for acute and chronic monitoring of subtoxicity were defined. Plasma arginine vasopressin, and oxytocin levels were measured by RIA and LIA. Data were evaluated using SAS and ANOVA. Results: A stable in vivo control system had to be established to monitor the biological effects. The chlorobenzene exposures were standardized via gastrointestinal probe, in a final volume of 1.0 ml per day, at doses of 0.1 and 1.0 µg/kg body weight. The chlorobenzene potency model compounds were optimized during in vivo gastrointestinal exposure. Exposures were standardized: via gastrointestinal probe, 1 ml final volume per day, at doses of 0.1 and 1.0 µg/kg body weight. Experimental time intervals were 0–90 days. Discussion: In our work, we have succeeded in developing a test system to establish a validated method for monitoring chemical environmental exposures. We have also developed a standardised procedure for the determination of human toxicity potentials. Conclusion: A validated test system has been developed to test for persistent organic pollutants, which are nowadays a major health concern, making their testing of real relevance in clinical practice. Orv Hetil. 2025; 166(31): 1209–1216.</p>","PeriodicalId":19911,"journal":{"name":"Orvosi hetilap","volume":"166 31","pages":"1209-1216"},"PeriodicalIF":0.9000,"publicationDate":"2025-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Orvosi hetilap","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1556/650.2025.33353","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: By the 3rd millennium, the Earth as a living environment had been altered by environmental stresses. For 25 years, our research group has been thematically engaged in model studies of homeostatic disruptor effects. These have enabled thematic studies to follow the effects of chemical agents, e.g., the combined effects of chlorobenzenes (hexachlorobenzene : 1,2,4-trichlorobenzene 1 : 1), which have endocrine disrupting properties. Objective: We aimed to develop a test model system to investigate the effects of endocrine disruptors in a validated test system. Method: In the test system, male and female Wistar rats were used as model animals for in vivo studies. Subtoxicity was controlled by liver enzymes and body weight and physiological characterization. The exposure pathway was standardized. Then, the organism-level sub-toxic dose range and the time windows for acute and chronic monitoring of subtoxicity were defined. Plasma arginine vasopressin, and oxytocin levels were measured by RIA and LIA. Data were evaluated using SAS and ANOVA. Results: A stable in vivo control system had to be established to monitor the biological effects. The chlorobenzene exposures were standardized via gastrointestinal probe, in a final volume of 1.0 ml per day, at doses of 0.1 and 1.0 µg/kg body weight. The chlorobenzene potency model compounds were optimized during in vivo gastrointestinal exposure. Exposures were standardized: via gastrointestinal probe, 1 ml final volume per day, at doses of 0.1 and 1.0 µg/kg body weight. Experimental time intervals were 0–90 days. Discussion: In our work, we have succeeded in developing a test system to establish a validated method for monitoring chemical environmental exposures. We have also developed a standardised procedure for the determination of human toxicity potentials. Conclusion: A validated test system has been developed to test for persistent organic pollutants, which are nowadays a major health concern, making their testing of real relevance in clinical practice. Orv Hetil. 2025; 166(31): 1209–1216.

[内分泌干扰物对复杂健康维持影响的方法学监测]。
到第三个千年,地球作为一个生存环境已经被环境压力所改变。25年来,我们的研究小组一直致力于稳态干扰效应的模型研究。这使得专题研究能够跟踪化学剂的影响,例如具有内分泌干扰特性的氯苯(六氯苯:1,2,4-三氯苯1:1)的综合影响。目的:我们旨在开发一个测试模型系统来研究内分泌干扰物在一个有效的测试系统中的影响。方法:在实验系统中,以雄性和雌性Wistar大鼠为模型动物进行体内研究。亚毒性受肝酶、体重和生理特性控制。暴露途径标准化。然后,确定了生物水平亚毒性剂量范围和急性和慢性亚毒性监测的时间窗。采用RIA和LIA检测血浆精氨酸、抗利尿激素和催产素水平。采用SAS和方差分析对数据进行评价。结果:必须建立稳定的体内控制系统来监测生物效应。通过胃肠道探针将氯苯暴露标准化,最终体积为每天1.0 ml,剂量为0.1和1.0µg/kg体重。在体内胃肠道暴露条件下,优化了氯苯效价模型化合物。暴露标准化:通过胃肠道探针,每天1ml终体积,剂量分别为0.1和1.0µg/kg体重。实验时间间隔为0 ~ 90 d。讨论:在我们的工作中,我们已经成功地开发了一个测试系统,以建立一个有效的方法来监测化学环境暴露。我们还制定了测定人体毒性潜势的标准化程序。结论:一个有效的测试系统已经开发用于测试持久性有机污染物,这是当今主要的健康问题,使他们的测试在临床实践中具有真正的相关性。Orv Hetil. 2025;166(31): 1209 - 1216。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Orvosi hetilap
Orvosi hetilap MEDICINE, GENERAL & INTERNAL-
CiteScore
1.20
自引率
50.00%
发文量
274
期刊介绍: The journal publishes original and review papers in the fields of experimental and clinical medicine. It covers epidemiology, diagnostics, therapy and the prevention of human diseases as well as papers of medical history. Orvosi Hetilap is the oldest, still in-print, Hungarian publication and also the one-and-only weekly published scientific journal in Hungary. The strategy of the journal is based on the Curatorium of the Lajos Markusovszky Foundation and on the National and International Editorial Board. The 150 year-old journal is part of the Hungarian Cultural Heritage.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信